Venkat Pharma Financials

BSE: 532093

₹3.40

₹-0.17 (-4.76%)

As on 18-May-2015IST

Market cap

₹2 Cr

Revenue (TTM)

₹-- Cr

P/E Ratio

--

P/B Ratio

-0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Operating Revenue	--	--	--	--	--	36.42
Total Income	--	--	0.00	0.00	--	36.42
Total Expenditure	0.03	0.03	0.02	0.04	0.21	34.50
EBITDA	-0.03	-0.03	-0.02	-0.04	-0.21	1.93
Depreciation	--	0.02	0.02	0.02	0.04	0.26
EBIT	-0.03	-0.04	-0.04	-0.07	-0.24	1.67
Interest	--	0.00	0.00	0.00	0.00	1.37
Other Income	--	--	0.00	0.00	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.03	-0.04	-0.04	-0.06	-0.24	0.30
Provision for Tax	--	--	--	--	0.01	0.08
Profit after Tax	-0.03	-0.04	-0.04	-0.06	-0.25	0.22

Liabilities (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Shareholder's Funds	4.99	-2.54	-2.50	-2.44	-2.38	6.89
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	19.20	19.07	19.07	16.06	16.06	12.08
Current Liabilities	1.37	1.33	1.42	4.39	4.47	9.09
Total Liabilities	25.56	18.00	18.12	18.14	18.29	28.11

Assets (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Non-Current Assets	0.97	0.85	0.87	0.89	0.92	1.42
Current Assets	24.58	17.02	17.13	17.11	17.22	26.57
Total Assets	25.56	18.00	18.12	18.14	18.29	28.11
Total Debt*	--	19.22	19.20	16.19	16.19	12.13
Net Current Assets	23.21	15.68	15.71	12.72	12.75	17.48
Contingent Liabilities	--	10.39	10.39	8.69	--	--

Cashflow (₹ Cr)	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Cash From Operating Activities	--	0.00	-0.01	0.00	0.00	0.28
Cash Flow from Investing Activities	--	--	0.01	0.01	--	-0.12
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	--	0.00	-0.01	0.00	0.00	0.15

Financials Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Adjusted EPS (₹)	-0.05	-0.09	-0.07	-0.13	-0.51	0.48
Cash EPS (₹)	--	-0.06	-0.04	-0.08	-0.43	1.06
Adjusted Book Value (₹)	--	-5.09	-5.00	-4.93	-4.80	15.09
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.00	-0.03	0.00	-0.01	0.61
Free Cash Flow per Share (₹)	--	0.00	-0.03	0.00	-0.02	0.34

Profitability Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
ROCE (%)	--	-0.26	-0.24	-0.46	-1.48	10.20
ROE (%)	--	--	--	--	-11.44	3.24
ROA (%)	-0.21	-0.25	-0.20	-0.35	-1.10	0.85
EBIT Margin (%)	--	--	--	--	--	4.57
Net Margin (%)	--	--	-1,304.68	-1,620.85	--	0.60
Cash Profit Margin (%)	--	--	--	--	--	1.32

Growth Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Revenue Growth (%)	--	--	--	--	-100.00	-23.84
EBIT Growth (%)	15.63	-12.87	42.25	72.20	--	121.36
Net Profit Growth (%)	15.63	-21.39	42.88	74.84	-216.73	13.94
EPS Growth (%)	15.51	-21.48	42.89	74.84	-205.97	13.94
Book Value Growth (%)	--	-1.77	-1.48	-2.66	-135.06	3.52

Valuation Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Price / Earnings	--	--	--	--	--	66.35
Price / Book Value	-0.66	-0.49	-0.48	-0.68	-1.00	2.11
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-774.29	-726.97	-1,165.84	-451.11	-90.42	13.65
Close Price (₹)	2.57	2.50	2.40	3.33	4.79	31.85
High Price (₹)	3.78	5.69	6.02	5.51	8.25	60.00
Low Price (₹)	1.47	1.87	1.82	2.67	2.79	17.10
Market Cap (₹ Cr)	1.70	--	--	--	--	14.42

Solvency Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Debt to Equity	3.85	-7.57	-7.70	-6.59	-6.76	1.78
Short term debt to equity ratio	0.01	-0.01	--	--	--	--
Current Ratio	17.98	12.77	12.08	3.90	3.85	2.92
Quick Ratio	16.50	11.25	10.57	3.41	3.37	2.14
Interest Coverage	--	-204.43	-156.40	-320.65	-1,194.76	1.22

Operating Efficiency Ratios	TTM	Mar-13	Mar-12	Mar-11	Mar-10	Mar-05	Mar-04	Mar-02	Mar-01	Mar-00	Mar-99
Debtors to sales (%)	--	--	--	--	--	40.62
Asset Turnover	--	--	--	--	--	1.42
Receivable days	--	--	--	--	--	160.30
Inventory Days	--	--	--	--	--	46.54
Payable days	--	--	--	--	--	64.76
Cash Conversion Cycle	--	--	--	--	--	142.08

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.